tiprankstipranks
Trending News
More News >
Braskem SA (BAK)
NYSE:BAK
Advertisement

Braskem SA (BAK) AI Stock Analysis

Compare
290 Followers

Top Page

BAK

Braskem SA

(NYSE:BAK)

Rating:45Neutral
Price Target:
$3.00
▼(-12.02% Downside)
Braskem SA's overall stock score reflects significant financial challenges, including high leverage and declining profitability, which are the most impactful factors. Technical analysis indicates a bearish trend, and valuation metrics are unattractive. Despite some positive developments highlighted in the earnings call, such as EBITDA growth and strategic initiatives, the company's financial instability remains a major concern.
Positive Factors
Debt Management
Liability management is not a big issue at least in the short-term, given that the company has a long debt profile with 65% maturing from 2030 onwards.
Leadership
Mr. Jens has vast experience including roles as a Board Member, CEO, CFO, CIO and Managing Director in different sectors, including infrastructure and petrochemicals.
Negative Factors
Financial Performance
Braskem's EBITDA is expected to be well below its mid-cycle level over the next years.
Geological Event
The Alagoas geological event remains one of the main risks in Braskem’s investment thesis and the company itself does not discard further provisions related to this matter.
Petrochemical Spreads
The outlook for petrochemical spreads will remain challenging given the weak current demand scenario and the strong capacity addition expected to come online in China.

Braskem SA (BAK) vs. SPDR S&P 500 ETF (SPY)

Braskem SA Business Overview & Revenue Model

Company DescriptionBraskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells chemicals, including ethylene, polymer and chemical grade propylene, butadiene, butene-1, benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins. This segment also produces and sells polyethylene (PE) and polypropylene (PP); supplies electricity and other inputs to second-generation producers; produces and sells of PE, including the production of green PE from renewable resources; and produces and sells polyvinyl chloride and caustic soda. The United States and Europe segment produces and sells PP in the United States and Germany. The Mexico segment produces and sells ethylene, high-density PE, and low-density PE in Mexico. It also manufactures, sells, imports, and exports chemicals, petrochemicals, and fules; produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases; and provides industrial services. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in Camaçari, Brazil.
How the Company Makes MoneyBraskem generates revenue primarily through the production and sale of its petrochemical products, including polyethylene, polypropylene, and PVC. The company operates several production facilities and has a diverse customer base across different sectors, which helps stabilize its revenue streams. Key revenue sources include sales to manufacturers in packaging, automotive, and construction industries. Additionally, Braskem has entered into strategic partnerships and joint ventures that enhance its market position and provide access to new technologies and markets. The company's focus on sustainability and development of bio-based plastics also positions it to capitalize on the growing demand for environmentally friendly products, contributing positively to its earnings.

Braskem SA Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q1-2025)
|
% Change Since: |
Next Earnings Date:Nov 05, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted strong performance in several segments, with significant EBITDA growth and a strong cash position. However, high leverage and market challenges, particularly in Europe, present concerns. The sentiment is balanced with both positive achievements and ongoing challenges.
Q1-2025 Updates
Positive Updates
Significant Increase in EBITDA
Braskem's consolidated recurring EBITDA for Q1 2025 was $224 million, a 121% increase compared to Q4 2024.
Net Profit Growth
The net profit attributable to shareholders was $113 million, driven by greater spreads of PE and chemicals and increased sales in international markets.
Strong Cash Position
Braskem's cash position was $2 billion at the end of Q1 2025, sufficient to cover debt maturities for the next 33 months without considering a $1 billion revolving credit line.
Operational Improvements
All segments showed higher utilization rates, and the global accident frequency rate was maintained at 0.92 events per million hours worked.
Renewables Segment Achievements
Green ethylene operations increased, and capacity at Triunfo was revised to 270,000 tons per year. The company celebrated 15 years of its Agriem Bio Base portfolio.
Inauguration of Ethane Import Terminal in Mexico
Braskem Idesa inaugurated an ethane import terminal with a capacity to receive and store 54,000 tons, supporting full operational capacity in the region.
Negative Updates
High Corporate Leverage
Corporate leverage stood at 7.92 times at the end of Q1 2025, indicating financial pressure.
Challenges in Europe Segment
European operations faced challenges due to decreased feedstock supplies, impacting production and sales.
Inventory Management Issues
Operating cash consumption was approximately BRL 936 million, driven by negative variations in working capital and inventory management challenges.
Potential Impact of Tariff Uncertainties
The second quarter is expected to be challenging due to prolonged shutdowns in international markets and new tariff scenarios.
Ongoing Alagoas Financial Provisions
Total provision for the Alagoas event was around BRL 17.6 billion, with ongoing financial impact.
Company Guidance
During Braskem's earnings call for the first quarter of 2025, significant guidance and metrics were shared. The company reported a consolidated recurring EBITDA of $224 million, marking a 121% increase compared to the previous quarter. Net profit attributable to shareholders was $113 million, buoyed by favorable international market spreads for PE and chemicals. Operationally, Braskem maintained high safety standards with an average global accident frequency rate of 0.92 events per million hours worked. The company's cash position stood at $2 billion, sufficient to cover debt maturities for the next 33 months without tapping into a $1 billion international revolving credit line. The Mexico segment achieved a recurring EBITDA of $37 million, an increase of 6% from the previous quarter, and the United States and Europe segment reported a recurring EBITDA of $20 million. The company also highlighted strategic initiatives, including the inauguration of an ethane import terminal in Mexico and a focus on increasing the production of green ethylene, with the capacity at Triunfo revised to 270,000 tons annually. Braskem's corporate debt profile remained elongated, with an average term of around nine years and 68% of the debt maturing from 2030. The company also discussed its strategic direction, emphasizing resilience, financial health, and transformation, with initiatives aimed at generating an additional $600 million in EBITDA growth by 2030.

Braskem SA Financial Statement Overview

Summary
Braskem SA faces significant financial challenges, including declining profitability, high leverage, and cash flow issues. Negative equity and substantial debt levels pose risks, and recent revenue declines and net losses compound the company's financial instability.
Income Statement
40
Negative
Braskem SA has seen a decline in total revenue from 2021 to 2024, with significant net losses reported in recent years. The Gross Profit Margin has decreased, reflecting pressure on profitability. The EBIT and EBITDA margins have also weakened, indicating operational challenges.
Balance Sheet
30
Negative
The balance sheet shows negative stockholders' equity as of 2024, indicating financial instability. The debt-to-equity ratio is not calculable due to negative equity, highlighting high leverage. The company has a substantial total debt, increasing financial risk. ROE is not meaningful with negative equity.
Cash Flow
45
Neutral
Braskem SA's cash flow situation is concerning, with negative free cash flow reported for the past two years. Operating cash flow has improved since 2023 but remains weak compared to historical levels. The free cash flow to net income ratio is negative, indicating cash flow challenges.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue77.41B70.57B96.52B105.63B58.54B
Gross Profit6.00B3.02B11.36B32.06B11.21B
EBITDA2.70B3.80B8.84B27.28B-1.65B
Net Income-11.32B-4.58B-820.00M13.98B-7.02B
Balance Sheet
Total Assets101.58B91.74B88.05B92.56B86.08B
Cash, Cash Equivalents and Short-Term Investments16.77B19.14B14.76B11.34B16.17B
Total Debt73.72B59.91B52.78B53.53B59.56B
Total Liabilities105.85B88.46B81.94B86.36B89.95B
Stockholders Equity-4.78B3.99B7.32B7.87B-2.20B
Cash Flow
Free Cash Flow-1.33B-6.80B4.10B11.37B3.53B
Operating Cash Flow2.44B-2.27B8.95B14.79B6.29B
Investing Cash Flow-3.48B-4.53B-4.95B-3.38B-2.72B
Financing Cash Flow469.00M8.87B225.00M-16.97B2.17B

Braskem SA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.41
Price Trends
50DMA
3.22
Positive
100DMA
3.46
Negative
200DMA
3.86
Negative
Market Momentum
MACD
0.06
Negative
RSI
58.48
Neutral
STOCH
60.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BAK, the sentiment is Positive. The current price of 3.41 is above the 20-day moving average (MA) of 3.14, above the 50-day MA of 3.22, and below the 200-day MA of 3.86, indicating a neutral trend. The MACD of 0.06 indicates Negative momentum. The RSI at 58.48 is Neutral, neither overbought nor oversold. The STOCH value of 60.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BAK.

Braskem SA Risk Analysis

Braskem SA disclosed 74 risk factors in its most recent earnings report. Braskem SA reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Braskem SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$778.77M14.7910.28%8.63%-7.24%-7.30%
61
Neutral
$10.27B6.370.76%2.91%3.10%-36.03%
59
Neutral
$1.91B-10.43%9.07%-1.56%-259.58%
48
Neutral
$17.30B75.91-5.59%10.25%-2.82%-186.41%
47
Neutral
$5.04B6.84-25.69%1.70%-5.83%-183.85%
45
Neutral
$1.37B-8638.28%-3.33%44.37%
45
Neutral
$657.88M-14.11%10.17%0.20%-292.54%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BAK
Braskem SA
3.41
-3.39
-49.85%
CE
Celanese
46.43
-72.74
-61.04%
HUN
Huntsman
11.03
-9.20
-45.48%
TROX
TRONOX
4.18
-7.40
-63.90%
WLKP
Westlake Chemical PRN
21.85
1.33
6.48%
DOW
Dow Inc
23.91
-23.19
-49.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 23, 2025